Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPECC1L | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | TMBIM1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | B3GNT9 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
mRNA | CUL7 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | ACAA1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | HECW2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | STC2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | NDRG1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | CYBB | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | CCDC88A | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |